Organization
Sanofi
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Sanofi

... and Ablynx, the latter of which was set to be acquired by Sanofi as part of a multibillion dollar takeover. UCB and Biogen's study enrolled ...
... station. It is not clear if a deal has been reached. Neither Sanofi nor Cambridge Crossing developer DivcoWest would comment, and several people with knowledge ...
... corticosteroid use and improved lung function Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the U.S. Food and Drug Administration has approved Dupixent® (dupilumab) ...
... PR Newswire Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi will present data from analyses of the Kevzara® (sarilumab) Phase 3 clinical ...
... Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi receives positive CHMP opinion for dengue vaccineParis, ...
... Sanofi has reported positive results from two Phase III clinical trials for its ...
... Sanofi: Dupixent(R) (dupilumab) showed positive topline results in two Phase 3 trials of ...
... -- Additional milestones achieved under the Sanofi collaboration which is focused on treating diseases of the central nervous system ...
... Area real estate brokers and others said Sanofi, which has about 5,000 employees in Massachusetts, may be aiming to consolidate ...
... Sanofi's annual flu-shot mobilization is in full swing, and as tens of millions ...
Subscribe now for full coverage on Sanofi
Start My Free Trial